Exco InTouch

Rated 0.00(0) — Exco InTouch

The EUROSTAD study OBS14620 eDiary App has been developed for the Prospective Observational Study to characterise the medication history, demographic characteristics and previous treatment of Atopic Dermatitis (AD) in patients treated with systemic immuno

Rated 5.00(1) — Exco InTouch

Novartis 197-P-322 App has been developed by Novartis for their blunt trauma pain protocol. The App will collect diary information from patients registered into this clinical trial.*Note: this app requires an activation code and can only be accessed...

Rated 4.13(447) — Exco InTouch

TARGET My Hives – connecting the chronic urticaria community.Around 1 in every 100 people are affected by the itching, redness and burning pain of chronic urticaria. If you’re one of them, try TARGET My Hives, the first community app for anyone impacted..

Rated 3.20(5) — Exco InTouch

MeAndMyCOPD is a support service developed by AstraZeneca to help people with Chronic Obstructive Pulmonary Disease (COPD) manage their condition. The service provides patients with individual, real-time information on their condition and is able to...

Rated 0.00(0) — Exco InTouch

The Orthopedic Surgery Study 0304173 e-diary App has been developed for the Prospective Observational Study to Characterize Burden of Illness in Patients Undergoing Orthopedic Procedures at Ambulatory Surgery Centers. The App will collect e-diary informat

Rated 0.00(0) — Exco InTouch

The Turbu+ service is a support service developed by AstraZeneca for patients diagnosed with Chronic Obstructive Pulmonary Disease (COPD) or Asthma who use TurbuPlus hardware. The Turbu+ service is intended for single-patient use as an electronic data...